Maxim Group Reaffirms “Hold” Rating for CNS Pharmaceuticals (NASDAQ:CNSP)
Maxim Group reissued their hold rating on shares of CNS Pharmaceuticals (NASDAQ:CNSP – Free Report) in a report issued on Tuesday morning,Benzinga reports. Separately, Alliance Global Partners upgraded CNS Pharmaceuticals to a “strong-buy” rating in a report on Friday, January 24th. View Our Latest Stock Report on CNSP CNS Pharmaceuticals Stock Performance Shares of CNS […]
Maxim Group reissued their hold rating on shares of CNS Pharmaceuticals (NASDAQ:CNSP – Free Report) in a report issued on Tuesday morning,Benzinga reports. Separately, Alliance Global Partners upgraded CNS Pharmaceuticals to a “strong-buy” rating in a report on Friday, January 24th. View Our Latest Stock Report on CNSP CNS Pharmaceuticals Stock Performance Shares of CNS […]
